DSM Biomedical actively exploits venturing and licensing opportunities to
boost the innovation process, setting up business models that are typical of
knowledge-based rather than production-based businesses, including the
licensing of intellectual property.
Through DSM Venturing, DSM has
equity stakes in several start-ups focusing on key areas of the biomedical
market. These include:
-
Harland Medical Systems , Inc.
markets technologies and solutions in medical coating applications.
-
Micromuscle AB develops and
commercializes electro-active polymer technology for use in medical and life
science applications.
-
Oxford Performance Materials Inc. (OPM)
is active in the ultra-high performance thermoplastic polymers market with a
focus on (bio)medical applications.
-
Xylos Corporation is active in
healthcare products based on biosynthesized cellulose. Application areas are
advanced wound dressings, surgical repair products and tissue engineering.
